These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26365496)

  • 21. Next generation sequencing technologies for rare Mendelian disorders: striking potential and ongoing challenges.
    Hoffjan S
    Mol Cell Probes; 2015 Oct; 29(5):259. PubMed ID: 26257290
    [No Abstract]   [Full Text] [Related]  

  • 22. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.
    Rotunno M; Barajas R; Clyne M; Hoover E; Simonds NI; Lam TK; Mechanic LE; Goldstein AM; Gillanders EM
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1519-1534. PubMed ID: 32467344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using population data for assessing next-generation sequencing performance.
    Houniet DT; Rahman TJ; Al Turki S; Hurles ME; Xu Y; Goodship J; Keavney B; Santibanez Koref M
    Bioinformatics; 2015 Jan; 31(1):56-61. PubMed ID: 25236458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for whole genome sequencing in diagnostics for rare diseases.
    Souche E; Beltran S; Brosens E; Belmont JW; Fossum M; Riess O; Gilissen C; Ardeshirdavani A; Houge G; van Gijn M; Clayton-Smith J; Synofzik M; de Leeuw N; Deans ZC; Dincer Y; Eck SH; van der Crabben S; Balasubramanian M; Graessner H; Sturm M; Firth H; Ferlini A; Nabbout R; De Baere E; Liehr T; Macek M; Matthijs G; Scheffer H; Bauer P; Yntema HG; Weiss MM
    Eur J Hum Genet; 2022 Sep; 30(9):1017-1021. PubMed ID: 35577938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of next generation sequencing technology in Mendelian movement disorders.
    Wang Y; Pan X; Xue D; Li Y; Zhang X; Kuang B; Zheng J; Deng H; Li X; Xiong W; Zeng Z; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):197-205. PubMed ID: 26932219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Developments and Possibilities in Reanalysis and Reinterpretation of Whole Exome Sequencing Datasets for Unsolved Rare Diseases Using Machine Learning Approaches.
    Setty ST; Scott-Boyer MP; Cuppens T; Droit A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases.
    Wilke MVMB; Klee EW; Dhamija R; Fervenza FC; Thomas B; Leung N; Hogan MC; Hager MM; Kolbert KJ; Kemppainen JL; Loftus EC; Leitzen KM; Vitek CR; McAllister T; Lazaridis KN; Pinto E Vairo F
    Orphanet J Rare Dis; 2024 May; 19(1):216. PubMed ID: 38790019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Explanatory chapter: next generation sequencing.
    Yegnasubramanian S
    Methods Enzymol; 2013; 529():201-8. PubMed ID: 24011047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of exome sequencing trio-like strategy based on pooled parental DNA for diagnosis and translational research in rare diseases.
    Tran Mau-Them F; Duffourd Y; Vitobello A; Bruel AL; Denommé-Pichon AS; Nambot S; Delanne J; Moutton S; Sorlin A; ; Couturier V; Bourgeois V; Chevarin M; Poe C; Mosca-Boidron AL; Callier P; Safraou H; Faivre L; Philippe C; Thauvin-Robinet C
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1836. PubMed ID: 34716697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next generation sequencing technology and genomewide data analysis: Perspectives for retinal research.
    Chaitankar V; Karakülah G; Ratnapriya R; Giuste FO; Brooks MJ; Swaroop A
    Prog Retin Eye Res; 2016 Nov; 55():1-31. PubMed ID: 27297499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next Generation Sequencing (NGS) Strategies for Genetic Testing of Cerebral Cavernous Malformation (CCM) Disease.
    Benedetti V; Pellegrino E; Brusco A; Piva R; Retta SF
    Methods Mol Biol; 2020; 2152():59-75. PubMed ID: 32524544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Modifiers and Rare Mendelian Disease.
    Rahit KMTH; Tarailo-Graovac M
    Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32106447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.
    Lin X; Tang W; Ahmad S; Lu J; Colby CC; Zhu J; Yu Q
    Hear Res; 2012 Jun; 288(1-2):67-76. PubMed ID: 22269275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease.
    Gonorazky HD; Naumenko S; Ramani AK; Nelakuditi V; Mashouri P; Wang P; Kao D; Ohri K; Viththiyapaskaran S; Tarnopolsky MA; Mathews KD; Moore SA; Osorio AN; Villanova D; Kemaladewi DU; Cohn RD; Brudno M; Dowling JJ
    Am J Hum Genet; 2019 Mar; 104(3):466-483. PubMed ID: 30827497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel bioinformatic developments for exome sequencing.
    Lelieveld SH; Veltman JA; Gilissen C
    Hum Genet; 2016 Jun; 135(6):603-14. PubMed ID: 27075447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare Does Not Mean Worthless: How Rare Diseases Have Shaped Neurodevelopment Research in the NGS Era.
    Zaghi M; Banfi F; Bellini E; Sessa A
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalised analytics for rare disease diagnostics.
    Anderson D; Baynam G; Blackwell JM; Lassmann T
    Nat Commun; 2019 Nov; 10(1):5274. PubMed ID: 31754101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GeneYenta: a phenotype-based rare disease case matching tool based on online dating algorithms for the acceleration of exome interpretation.
    Gottlieb MM; Arenillas DJ; Maithripala S; Maurer ZD; Tarailo Graovac M; Armstrong L; Patel M; van Karnebeek C; Wasserman WW
    Hum Mutat; 2015 Apr; 36(4):432-8. PubMed ID: 25703386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.